Clinical trial
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6…
NCT00441116 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00441116 |
|---|---|
| Title | A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia |
| Official title | An Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Dutasteride 0.5mg Once Daily for 6 Months in the Treatment of Male Subjects With Androgenetic Alopecia (Norwood-Hamilton Classification Type IIIv, IV and V) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alopecia |
| Intervention type | Drug |
| Interventions | Dutasteride 0.5mg oral tablets |
| Enrollment | 153 |
| Start date | Dec 15, 2006 |
| Primary completion | Jan 21, 2008 |
| Completion | Jan 21, 2008 |
| First posted | Feb 28, 2007 |
| Last update posted | Aug 16, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: